| TP1 | TP2 | TP3 | p |
---|---|---|---|---|
Patients with FFP administration | Â | Â | Â | Â |
   Reaction time (mm) | 19.4 (13.8–25.6) | 20 (15.9–23.9) | 17.4 (15.1–23) | 0.46 |
   Coagulation time (mm) | 16 (9.1–37.8) | 25.5 (10.2–45.7) | 25.1 (13–33.9) | 0.02 |
   Maximal amplitude (mm) | 34.2 (23.2–42.2) | 29 (22.5–43) | 29.7 (20.5–40.5) | 0.015 |
   Angle alpha (degree) | 30.2 (17–51.2) | 34.2 (18.5–45.7) | 21 (17.5–37) | 0.06 |
   Clot lysis | 100 (100-100) | 100 (100-100) | 100 (100-100) | 0.84 |
   Coagulation index (percent) | -2.2 (-14.4–2.5) | -5 (-11.5–1.9) | -4.7 (-8.6–1.1) | 0.9 |
   RHEP (mm) | 1 (-0.7–2.2) | 3 (-0.1–6.8) | 0.7 (-0.6–4.1) | 0.64 |
   MAPLT (mm) | 20 (12–30.3) | 21.5 (15–31) | 24 (13.8–32.2) | 0.22 |
Patients without FFP administration | Â | Â | Â | Â |
   Reaction time (mm) | 15.9 (13–19.4) | 16.8 (13–19.3) | 16.4 (10.9–20.5) | 0.71 |
   Coagulation time (mm) | 11.3 (7–19.7) | 9.4 (6.3–21) | 14.2 (5–32) | 0.6 |
   Maximal amplitude (mm) | 40 (32–52) | 37.5 (28.3–52.6) | 36.5 (24.8–53.3) | 0.006 |
   Angle alpha (degree) | 35.5 (28.5–51) | 47.5 (30–57) | 35.5 (21.2–57.7) | 0.028 |
   Clot lysis (percent) | 100 (98.6–100) | 100 (98.6–100) | 100 (97.8–100) | 0.77 |
   Coagulation index | 0.38 (-3.4–4.2) | -0.1 (-2.3–3.8) | 0.3 (-7.7–4.8) | 0.73 |
   RHEP (mm) | 0.7 (-0.4–2.8) | 2.9 (0.3–4.7) | 1.9 (0.7–4) | 0.03 |
   MAPLT (mm) | 24.4 (12.5–31.2) | 20 (8.5–27.5) | 13.5 (6.2–27.5) | 0.95 |